Prescribing intelligence for therapies relating to the gastro-intestinal system
The gastro-intestinal system is comprised of organs from the mouth to the anus and so this section covers a wide variety of therapies including, but not limited to therapies for irritable bowel syndrome (IBS), diarrhoea, constipation, peptic ulcers, pancreatic enzyme deficiency and haemorrhoids. Please click here for live data for ulcerative colitis and Crohn’s disease prescribing.
The number of prescription items for treatments relating to the gastro-intestinal system has been increasing each year, from 60 million prescription items in 2007 to 104 million in 2020. Net ingredient cost has varied over this period however. Proton pump inhibitors constitute over two thirds of the prescription items in this section.
The RxIndex below gives an up-to-date snapshot of the most frequently-prescribed brands in one of GPrX’s gastro-intestinal system sub-categories.